We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

AstraZeneca has joined the ranks of pharma companies seeking to bring drugs targeting lipoprotein(a) to market, paying $100 million upfront for rights to a drug developed by CSPC Pharmaceutical.

Radiance Biopharma Inc. bought its way into the ROR1 antibody-drug conjugate (ADC) space through a potential $1 billion-plus licensing deal, including a $15 million up-front payment, with CSPC ...

KUALA LUMPUR: Pharmaniaga Bhd 's wholly-owned subsidiary Pharmaniaga LifeScience Sdn Bhd has entered into a memorandum of understanding (MOU) with CSPC Holdings Co Ltd to explore a collaboration ...